These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Werner JL; Christopher-Stine L; Ghazarian SR; Pak KS; Kus JE; Daya NR; Lloyd TE; Mammen AL Arthritis Rheum; 2012 Dec; 64(12):4087-93. PubMed ID: 22933019 [TBL] [Abstract][Full Text] [Related]
3. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China. Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933 [TBL] [Abstract][Full Text] [Related]
4. Patient with statin-associated immune-mediated necrotizing myopathy presenting with subcutaneous edema, persistent bulbar weakness and absent anti-HMGCR. Ong SG; Ding HJ Int J Rheum Dis; 2017 Dec; 20(12):2175-2178. PubMed ID: 26692320 [No Abstract] [Full Text] [Related]
5. What is the third serological marker associated with immune-mediated necrotizing myopathy? Tanaka T; Suzuki S; Nishino I; Hamaguchi Y; Fujimoto T Scand J Rheumatol; 2017 Sep; 46(5):416-417. PubMed ID: 28067601 [No Abstract] [Full Text] [Related]
6. Anti-HMGCR autoantibodies in self-limiting statin-induced myopathy. Keating P; Young J; George P; Florkowski C; Spellerberg M; Kennedy N Int J Rheum Dis; 2017 Dec; 20(12):2179-2181. PubMed ID: 28185416 [No Abstract] [Full Text] [Related]
7. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies]. Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872 [TBL] [Abstract][Full Text] [Related]